These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25599940)

  • 1. Treatment of KPC-producing Enterobacteriaceae: suboptimal efficacy of polymyxins.
    de Oliveira MS; de Assis DB; Freire MP; Boas do Prado GV; Machado AS; Abdala E; Pierrotti LC; Mangini C; Campos L; Caiaffa Filho HH; Levin AS
    Clin Microbiol Infect; 2015 Feb; 21(2):179.e1-7. PubMed ID: 25599940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial treatment and outcomes of critically ill patients with OXA-48like carbapenemase-producing Enterobacteriaceae infections.
    Lowman W; Schleicher G
    Diagn Microbiol Infect Dis; 2015 Feb; 81(2):138-40. PubMed ID: 25497419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
    Tumbarello M; Sanguinetti M; Montuori E; Trecarichi EM; Posteraro B; Fiori B; Citton R; D'Inzeo T; Fadda G; Cauda R; Spanu T
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1987-94. PubMed ID: 17387156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating infections caused by carbapenemase-producing Enterobacteriaceae.
    Tzouvelekis LS; Markogiannakis A; Piperaki E; Souli M; Daikos GL
    Clin Microbiol Infect; 2014 Sep; 20(9):862-72. PubMed ID: 24890393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment.
    Zarkotou O; Pournaras S; Tselioti P; Dragoumanos V; Pitiriga V; Ranellou K; Prekates A; Themeli-Digalaki K; Tsakris A
    Clin Microbiol Infect; 2011 Dec; 17(12):1798-803. PubMed ID: 21595793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival.
    Balkan II; Aygün G; Aydın S; Mutcalı SI; Kara Z; Kuşkucu M; Midilli K; Şemen V; Aras S; Yemişen M; Mete B; Özaras R; Saltoğlu N; Tabak F; Öztürk R
    Int J Infect Dis; 2014 Sep; 26():51-6. PubMed ID: 24998423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance in Enterobacteriaceae in Brazil: focus on β-lactams and polymyxins.
    Sampaio JL; Gales AC
    Braz J Microbiol; 2016 Dec; 47 Suppl 1(Suppl 1):31-37. PubMed ID: 27825605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteremia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae other than Escherichia coli and Klebsiella.
    Huang SS; Lee MH; Leu HS
    J Microbiol Immunol Infect; 2006 Dec; 39(6):496-502. PubMed ID: 17164953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by
    Guimarães T; Nouér SA; Martins RCR; Perdigão Neto LV; Martins WMBS; Narciso Barbosa AC; Ferreira ALP; Costa SF; Gales AC
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31358592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-treatment of carbapenemase-producing Enterobacteriaceae.
    Rihani DS; Wallace MR; Sieger BE; Waite RA; Fox M; Brown SA; Deryke CA
    Scand J Infect Dis; 2012 May; 44(5):325-9. PubMed ID: 22200121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiclonal dispersal of KPC genes following the emergence of non-ST258 KPC-producing Klebsiella pneumoniae clones in Madrid, Spain.
    Ruiz-Garbajosa P; Curiao T; Tato M; Gijón D; Pintado V; Valverde A; Baquero F; Morosini MI; Coque TM; Cantón R
    J Antimicrob Chemother; 2013 Nov; 68(11):2487-92. PubMed ID: 23788480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
    Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
    Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections.
    Trecarichi EM; Cauda R; Tumbarello M
    Future Microbiol; 2012 Oct; 7(10):1173-89. PubMed ID: 23030423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective Observational Study from a Chinese Network of the Impact of Combination Therapy versus Monotherapy on Mortality from Carbapenem-Resistant
    Wang X; Wang Q; Cao B; Sun S; Zhang Y; Gu B; Li B; Liao K; Zhao F; Jin L; Jin C; Yang C; Pei F; Zhang Z; Wang H
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy.
    Tumbarello M; Viale P; Viscoli C; Trecarichi EM; Tumietto F; Marchese A; Spanu T; Ambretti S; Ginocchio F; Cristini F; Losito AR; Tedeschi S; Cauda R; Bassetti M
    Clin Infect Dis; 2012 Oct; 55(7):943-50. PubMed ID: 22752516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Quick Sepsis-Related Organ Failure Assessment Suggest the Use of Initial Empirical Carbapenem Therapy in Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Bacteria? :A Multicenter Case-Control Study.
    Mitsuboshi S; Tsuruma N; Watanabe K; Takahashi S; Nakashita M; Ito A; Kobayashi K; Tsugita M
    Jpn J Infect Dis; 2019 Mar; 72(2):124-126. PubMed ID: 30381688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
    Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D
    Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefepime therapy for monomicrobial bacteremia caused by cefepime-susceptible extended-spectrum beta-lactamase-producing Enterobacteriaceae: MIC matters.
    Lee NY; Lee CC; Huang WH; Tsui KC; Hsueh PR; Ko WC
    Clin Infect Dis; 2013 Feb; 56(4):488-95. PubMed ID: 23090931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain.
    Palacios-Baena ZR; Oteo J; Conejo C; Larrosa MN; Bou G; Fernández-Martínez M; González-López JJ; Pintado V; Martínez-Martínez L; Merino M; Pomar V; Mora-Rillo M; Rivera MA; Oliver A; Ruiz-Carrascoso G; Ruiz-Garbajosa P; Zamorano L; Bautista V; Ortega A; Morales I; Pascual Á; Campos J; Rodríguez-Baño J;
    J Infect; 2016 Feb; 72(2):152-60. PubMed ID: 26546855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.